Expression and localisation of extracellular matrix degrading proteases and their inhibitor during the oestrous cycle and after induced luteolysis in the bovine corpus luteum

Reproduction

Volumn 134, Issue 3, 2007, Pages 535-547

  Kliem, H ^b   Welter, H ^a   Kraetzl, W D ^b   Steffl, M ^a   Meyer, H H D ^b   Schams, D ^b   Berisha, B ^b  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPROSTENOL; GELATINASE A; GELATINASE B; GONADORELIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROSTAGLANDIN F2 ALPHA; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME LOCALIZATION; ESTRUS CYCLE; EXTRACELLULAR MATRIX; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION; GENETIC CODE; IMMUNOHISTOCHEMISTRY; LUTEAL CELL; LUTEAL PHASE; LUTEOLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

BOVINAE;

EID: 34548558862     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/REP-06-0172     Document Type: Article

References (68)

1. Alexander CM, Howard EW, Bissell M & Werb Z 1996 Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. Journal of Cell Biology 135 1669-1677.
2. Bacharach E, Itin A & Keshet E 1992 In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. PNAS 89 10686-10690.
3. Bacharach E, Itin A & Keshet E 1998 Apposition-dependent induction of plasminogen activator inhibitor type 1 expression: a mechanism for balancing pericellular proteolysis during angiogenesis. Blood 92 939-945.
4. Berisha B, Schams D, Kosmann M, Amselgruber W & Einspanier R 2000a Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biology of Reproduction 63 1106-1114.
5. Berisha B, Schams D, Kosmann M, Amselgruber W & Einspanier R 2000b Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles. Journal of Endocrinology 167 371-382.
6. Berisha B, Pfaffl MW & Schams D 2002 Expression of estrogen and progesterone receptors in the bovine ovary during estrous cycle and pregnancy. Endocrine 17 207-214.
7. Berisha B, Steffl M, Amselgruber W & Schams D 2006a Changes in fibroblast growth factor 2 and its receptors in bovine follicle before and after GnRH application and after ovulation. Reproduction 131 319-329.
8. Berisha B, Welter H, Shimizu T, Miyamoto A, Meyer HH & Schams D 2006b Expression of fibroblast growth factor I (FGF1) and FGF7 in mature follicles during the periovulatory period after GnRH in the cow. Journal of Reproduction and Development 52 307-313.
9. Bian J & Sun Y 1997 Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Molecular and Cellular Biology 17 6330-6338.
10. Brannstrom M, Pascoe V, Norman RJ & McClure N 1994 Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertility and Sterility 61 488-495.
11. Chapman HA, Yang XL, Sailor LZ & Sugarbaker DJ 1990 Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophages. Possible role in lung injury. Journal of Immunology 145 3398-3405.
12. Curry TE Jr & Osteen KG 2003 The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocrine Reviews 24 428-465.
13. Davis JS, Rueda BR & Spanel-Borowski K 2003 Microvascular endothelial cells of the corpus luteum. Reproductive Biology and Endocrinology 1 89.
14. Djonov V, Hogger K, Sedlacek R, Laissue J & Draeger A 2001 MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. Journal of Pathology 195 147-155.
15. Estreicher A, Muhlhauser J, Carpentier JL, Orci L & Vassalli JD 1990 The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. Journal of Cell Biology 111 783-792.
16. Feng Q, Liu K, Hu ZY, Zou RJ, Yang SC & Liu YX 1993 The possible involvement of tissue type plasminogen activator in luteolysis of rhesus monkey. Human Reproduction 8 1640-1644.
17. Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M & Ziche M 1998 Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. Laboratory Investigation 78 1109-1119.
18. Gottsch ML, Van Kirk EA & Murdoch WJ 2001 Role of matrix metalloproteinase-2 in the folliculo-luteal transition of ewes. Reproduction 124 347-352.
19. Hart PH, Vitti GF, Burgess DR, Singleton DK & Hamilton JA 1989 Human monocytes can produce tissue-type plasminogen activator. Journal of Experimental Medicine 169 1509-1514.
20. Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, Durden DL, Erdreich-Epstein A & DeClerck YA 2001 Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Research 61 5587-5594.
21. Jo M & Curry Jr TE 2004 Regulation of matrix metalloproteinase-19 messenger RNA expression in the rat ovary. Biology of Reproduction 71 1796-1806.
22. Juengel JL, Smith GW, Smith MF, Youngquist RS & Garverick HA 1994 Pattern of protein production by bovine corpora lutea during luteolysis and characterization of expression of two major secretory products of regressing corpora lutea. Journal of Reproduction and Fertility 100 515-520.
23. Khan KM & Falcone DJ 1997 Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. Journal of Biological Chemistry 272 8270-8275.
24. Kirchheimer JC, Nong YH & Remold HG 1988 IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes. Journal of Immunology 141 4229-4234.
25. Kolb C, Mauch S, Krawinkel U & Sedlacek R 1999 Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. Experimental Cell Research 250 122-130.
26. Lamoreaux WJ, Fitzgerald ME, Reiner A, Hasty KA & Charles ST 1998 Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvascular Research 55 29-42.
27. Liu YX, Chen YX, Shi FW & Feng Q 1995 Studies on the role of plasminogen activators and plasminogen activator inhibitor type-1 in rat corpus luteum of pregnancy. Biology of Reproduction 53 1131-1138.
28. Liu K, Liu YX, Hu ZY, Zou RY, Chen YJ, Mu XM & Ny T 1997 Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression. Molecular and Cellular Endocrinology 133 109-116.
29. Liu K, Feng Q, Gao HJ, Hu ZY, Zou RJ, Li YC & Liu YX 2003 Expression and regulation of plasminogen activators, plasminogen activator inhibitor type-1, and steroidogenic acute regulatory protein in the rhesus monkey corpus luteum. Endocrinology 144 3611-3617.
30. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 402-408.
31. Luck MR & Zhao Y 1993 Identification and measurement of collagen in the bovine corpus luteum and its relationship with ascorbic acid and tissue development. Journal of Reproduction and Fertility 99 647-652.
32. Mandriota SJ & Pepper MS 1997 Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. Journal of Cell Science 110 2293-2302.
33. Moses MA 1997 The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells 15 180-189.
34. Mueller O, Lightfoot S & Schroeder A 2004 RNA integrity number (RIN)-standardization of RNA quality control. Agilent Application Note Publication Number-5989-1165EN 1-8.
35. Murdoch WJ & Steadman LE 1991 Investigations concerning the relationship of ovarian eosinophilia to ovulation and luteal function in the sheep. American Journal of Reproductive Immunology 25 81-87.
36. Neuvians TP, Berisha B & Schams D 2004a Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) expression during induced luteolysis in the bovine corpus luteum. Molecular Reproduction and Development 64 389-395.
37. Neuvians TP, Schams D, Berisha B & Pfaffl MW 2004b Involvement of pro-inflammatory cytokines, mediators of inflammation, and basic fibroblast growth factor in prostaglandin F2alpha-induced luteolysis in bovine corpus luteum. Biology of Reproduction 70 473-480
38. Ny T, Wahlberg P & Brandstrom IJ 2002 Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinases systems. Molecular and Cellular Endocrinology 187 29-38.
39. Partridge CR, Hawker JR Jr & Forough R 2000 Overexpression of a secretory form of FGF-1 promotes MMP-1 -mediated endothelial cell migration. Journal of Cellular Biochemistry 78 487-499.
40. Penny LA, Armstrong D, Bramley TA, Webb R, Collins RA & Watson ED 1999 Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after induced luteolysis. Journal of Reproduction and Fertility 115 87-96.
41. Pfaffl MW, Tichopad A, Prgomet C & Neuvians TP 2004 Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - excel-based tool using pair-wise correlations. Biotechnology Letters 26 509-515.
42. Plesner T, Behrendt N & Ploug M 1997 Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells 15 398-408.
43. Prakash BS, Meyer HH, Schallenberger E & van de Wiel DF 1987 Development of a sensitive enzymeimmunoassay (EIA) for progesterone determination in unextracted bovine plasma using the second antibody technique. Journal of Steroid Biochemistry 28 623-627.
44. Rasmussen R 2001 Quantification on the lightcycler. in Rapid Cycle Real-Time PCR, Methods and Applications, 1 edn, pp 21-34. Eds S Meuer, C Wittwer & K Nakagawara. Berlin: Verlag.
45. Reibiger I & Spanel-Borowski K 2000 Difference in localization of eosinophils and mast cells in the bovine ovary. Journal of Reproduction and Fertility 118 243-249.
46. Risau W 1997 Mechanisms of angiogenesis. Nature 386 671-674.
47. Sato Y, Abe M, Tanaka K, Iwasaka C, Oda N, Kanno S, Oikawa M, Nakano T & Igarashi T 2000 Signal transduction and transcriptional regulation of angiogenesis. Advances in Experimental Medicine and Biology 476 109-115.
48. Schams D & Berisha B 2002 Vascular endothelial growth factor (VEGF) and fibroblast growth factor TGF) family members in corpus luteum of farm animals. Advances in Reproduction VI 62-73.
49. Schams D & Berisha B 2004 Regulation of corpus luteum function in cattle - an overview. Reproduction in Domestic Animals 39 241-251.
50. Schams D, Berisha B, Neuvians T, Amselgruber W & Kraetzl WD 2003 Real-time changes of the local vasoactive peptide systems (angiotensin, endothelin) in the bovine corpus luteum after induced luteal regression. Molecular Reproduction and Development 65 57-66.
51. Shapiro SD, Kobayashi DK, Pentland AP & Welgus HG 1993 Induction of macrophage metalloproteinases by extracellular matrix. Journal of Biological Chemistry 268 8170-8175.
52. Silvester LM & Luck MR 1999 Distribution of extracellular matrix components in the developing ruminant corpus luteum: a wound repair hypothesis for luteinization. Journal of Reproduction and Fertility 116 187-198.
53. Sitrin RG, Todd RF, Mizukami IF, Gross TJ, Shollenberger SB & Gyetko MR 1994 Cytokine-specific regulation of urokinase receptor (Cd87) expression by U937 mononuclear phagocytes. Blood 84 1268-1275.
54. Smith MF, McIntush EW, Ricke WA, Kojima FN & Smith GW 1999 Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function. Journal of Reproduction and Fertility 54 367-381.
55. Standaert FE, Zamora CS & Chew BP 1991 Quantitative and qualitative changes in blood leukocytes in the porcine ovary. American journal of Reproductive Immunology 25 163-168.
56. Swartz JM, Bystrom J, Dyer KD, Nitto T, Wynn TA & Rosenberg HF 2004 Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes. Journal of Leukocyte Biology 76 812-819.
57. Townson DH, Warren JS, Flory CM, Naftalin DM & Keyes PL 1996 Expression of monocyte chemoattractant protein-1 in the corpus luteum of the rat. Biology of Reproduction 54 513-520.
58. Unemori EN, Ferrara N, Bauer EA & Amento EP 1992 Vascular endothelial growth factor induces interstitial collagenase expression in human enclothelial cells. Journal of Cellular Physiology 153 557-562.
59. Walter I & Boos A 2001 Matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor-2 of matrix metalloproteinases (TIMP-2) in the placenta and interplacental uterine wall in normal cows and in cattle with retention of fetal membranes. Placenta 22 473-483.
60. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM & Goldberg GI 1990 Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. Journal of Clinical Investigation 86 1496-1502.
61. Woessner JF Jr 2002 MMPs and TIMPs - an historical perspective. Molecular Biotechnology 22 33-49.
62. Woessner JF Jr, Morioka N, Zhu C, Mukaida T, Butler T & LeMaire WJ 1989 Connective tissue breakdown in ovulation. Steroids 54 491-499.
63. Young KA, Hennebold JD & Stouffer RL 2002 Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual. Molecular Human Reproduction 8 833-840.
64. Zhang Y, McCluskey K, Fujii K & Wahl LM 1998 Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-α, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. Journal of Immunology 161 3071-3076.
65. Zhang B, Yan L, Moses MA & Tsang PC 2002 Bovine membrane-type 1 matrix metalloproteinase: molecular cloning and expression in the corpus luteum. Biology of Reproduction 67 99-106.
66. Zhang B, Yan L, Tsang PC & Moses MA 2005 Matrix metalloproteinase-2 (MMP-2) expression and regulation by tumor necrosis factor alpha (TNF-α) in the bovine corpus luteum. Molecular Reproduction and Development 70 122-132.
67. Zhao Y & Luck MR 995 Gene expression and protein distribution of collagen, fibronectin and laminin in bovine follicles and corpora lutea. Journal of Reproduction and Fertility 104 115-123.
68. Zhou M, Zhang Y, Ardans JA & Wahl LM 2003 interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. Journal of Biological Chemistry 278 45406-45413.